advanced

Getting
Started

Founding
Members

Participating
Members

Receive Updates

Feedback

 

 

 

 

 
testing workgroup
Security workgroup
Data Issues Workgroup
Communications Workgroup

Testing Workgroup

The Testing Workgroup establishes recommended practices and provides a number of work products to facilitate the testing exchange between trading partners. The focus of this workgroup's effort is on the direct testing which occurs post-validation i.e. after the trading partner has successfully validated using either the free validation tool offered by the Collaborative or via other means.

Work Products

Testing Process Flow – 837/270/276 This Testing Process Flow outlines the general functional steps required for a trading partner to proceed from the point of initial registration with the MN HIPAA Collaborative Community to a production implementation.  This particular flow addresses the outbound 837, 270 and 276 transactions and is intended to be used as a general guideline in understanding testing process steps, work product usage and the recommended test continuum.
Testing Process Flow - 835/271/277 This Testing Process Flow outlines the inbound 835, 271 and 277 transactions.  Like the outbound process flow, it is to be used as a general guideline in understanding the testing process steps, work product usage and recommended testing continuum.
Test Profile Templates The Test Profile Template is used by trading partners to document their test readiness, capability and methodology. Use of the document facilitates communication between trading partners in order to expedite direct testing and establish reasonable expectations. Historically, this exchange has been the result of multiple communications with trading partner contacts resulting in incomplete or contradictory information regarding testing. The template is designed to solicit the collection of consistent information serving both the sender and the recipient of a given transaction (e.g. 837/835 etc).
Test Scenario Template The Test Scenario Template identifies generic, provider-neutral scenarios which should be considered for inclusion in direct testing based upon the originator's business lines and provided services. The scenario list is not exhaustive in its entirety but is intended to provide a basis for ensuring that representative test cases are included and sufficiently simulates production data exchanges. The template provides the originator with the opportunity to input specific test case scenarios, which once input, can be retained to facilitate future testing initiatives. Submission of a completed test scenario template should accompany the actual test file exchange unless already submitted with a prior test.
Test Non-Compliance Issues List Template Due to issues of timing or originator capability, non-compliance issues may result in obstacles to obtaining full compliance with WEDI-SNIP testing types 1-7. At that point, negotiation with a trading partner may establish that it is mutually beneficial to proceed with testing despite non-compliance. The Non-Compliance Issues List facilitates the communication of non-compliant issues between trading partners and documents the necessity of regression testing once full compliance is achieved.

Recommended Practices

Clearinghouse Role in Testing

The definition of a Clearinghouse and its role in the testing process

Recommended Acceptance Testing Criteria

This criteria defines what levels of test quality are sufficient to move to the next testing phase, or in the case of direct testing, migration to a production status.

Recommended Process Guidelines - When to Test/Retest

A list of when Providers and Payers should test or retest.

Privacy Statement